Use of peptide: HLA class II complexes to study specific T cells in myasthenia gravis

被引：0
|
作者：
Kishore, U [1 ]
Zhang, W [1 ]
Corlett, L [1 ]
Kelleher, A [1 ]
Shiono, H [1 ]
Willcox, N [1 ]
机构：
[1] John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DU, England
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2002年 / 73卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：229 / 229
页数：1
相关论文
共 50 条
  • [1] Use of peptide:HLA class II complexes to study specific T cells in autoimmune myasthenia gravis
    Kishore, U
    Zhang, W
    Corlett, L
    Waters, P
    Glaichenhaus, N
    Willcox, N
    MYASTHENIA GRAVIS AND RELATED DISORDERS: BIOMCHEMICAL BASIS FOR DISEASE OF THE NEUROMUSCULAR JUNCTION, 2003, 998 : 339 - 342
  • [2] HLA class I and class II polymorphisms in Saudi patients with myasthenia gravis
    Hajeer, A. H.
    Al Sawidan, F.
    Bohlega, S.
    Saleh, S.
    Sutton, P.
    Shubaili, A.
    Al Tahan, A.
    Al Jumah, M.
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2009, 36 (03) : 169 - 172
  • [3] HLA class II and class I polymorphism in Venezuelan patients with myasthenia gravis
    Fernández-Mestre, MT
    Vargas, V
    Montagnani, S
    Cotúa, M
    Ogando, V
    Layrisse, Z
    HUMAN IMMUNOLOGY, 2004, 65 (01) : 54 - 59
  • [4] HLA class II genotypes in Mexican Mestizo patients with myasthenia gravis
    García-Ramos, G
    Téllez-Zenteno, JF
    Zapata-Zúñiga, M
    Yamamoto-Furusho, JK
    Ruiz-Morales, JA
    Villarreal-Garza, C
    Vargas-Alarcón, G
    Estañol, B
    Llorente, L
    Granados, J
    EUROPEAN JOURNAL OF NEUROLOGY, 2003, 10 (06) : 707 - 710
  • [5] Thymus, thymoma, and specific T cells in myasthenia gravis
    Beeson, D
    Bond, AP
    Corlett, L
    Curnow, SJ
    Hill, ME
    Jacobson, LW
    Maclennan, C
    Meager, A
    Moody, AM
    Moss, P
    Nagvekar, N
    Newsom-Davis, J
    Pantic, N
    Roxanis, I
    Spack, EG
    Vincent, A
    Willcox, N
    MYASTHENIA GRAVIS AND RELATED DISEASES: DISORDERS OF THE NEUROMUSCULAR JUNCTION, 1998, 841 : 371 - 387
  • [6] DISTINCT TYPES OF MYASTHENIA GRAVIS DIFFER BY ASSOCIATION WITH HLA CLASS II ALLELES
    Testi, Manuela
    Greco, Giulia
    Troiano, Maria
    Rastelli, Emanuele
    Pompeo, Eugenio
    Antonini, Giovanni
    Andreani, Marco
    Massa, Roberto
    HLA, 2018, 91 (05) : 465 - 465
  • [7] Induction of tolerance in experimental autoimmune myasthenia gravis with solubilized MHC class II: Acetylcholine receptor peptide complexes
    Spack, EG
    McCutcheon, M
    Corbelletta, N
    Nag, B
    Passmore, D
    Sharma, SD
    JOURNAL OF AUTOIMMUNITY, 1995, 8 (06) : 787 - 807
  • [8] CHARACTERIZATION OF SPECIFIC T-CELLS IN MYASTHENIA-GRAVIS
    VINCENT, A
    WILLCOX, N
    IMMUNOLOGY TODAY, 1994, 15 (01): : 41 - 42
  • [9] Heterogeneity and immunotherapy of specific T-cells in myasthenia gravis
    Bond, A
    Corlett, L
    Nagvekar, N
    Jacobson, L
    Pantic, N
    Beeson, D
    Nicolle, M
    Vincent, A
    NewsomDavis, J
    Spack, E
    Willcox, N
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1997, 25 (02) : 665 - 670
  • [10] INCREASED EXPRESSION OF HLA-CLASS-II MOLECULES ON THE THYMIC EPITHELIAL-CELLS IN MYASTHENIA-GRAVIS
    MICIC, M
    DAMJANOVIC, M
    APOSTOLSKI, S
    POPESKOVIC, L
    GOSPAVIC, J
    ISAKOVIC, K
    FASEB JOURNAL, 1988, 2 (05): : A1175 - A1175
12345